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The lungs have evolved complex physical, biological and immunological defences to
prevent foreign material from entering the airway epithelial cells. These mechanisms can
also affect both viral and non-viral gene transfer agents, and significantly diminish the
effectiveness of airway gene-addition therapies. One strategy to overcome the physical
barrier properties of the airway is to transiently disturb the integrity of the epithelium prior
to delivery of the gene transfer vector. In this study, chemical (lysophosphatidylcholine,
LPC) and physical epithelium disruption using wire abrasion were compared for their
ability to improve airway-based lentiviral (LV) vector mediated transduction and reporter
gene expression in rats. When luciferase expression was assessed at 1-week post LV
delivery, LPC airway conditioning significantly enhanced gene expression levels in rat
lungs, while a long-term assessment in a separate cohort of rats at 12 months revealed
that LPC conditioning did not improve gene expression longevity. In rats receiving physical
perturbation to the trachea prior to gene delivery, significantly higher LacZ gene expression
levels were found when compared to LPC-conditioned or LV-only control rats when
evaluated 1-week post gene transfer. This proof-of-principle study has shown that airway
epithelial disruption strategies based on physical perturbation substantially enhanced LV-
mediated airway gene transfer in the trachea.
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INTRODUCTION
Airway gene-addition therapy is currently under development for treatment of a range of hereditary
and acquired pulmonary disorders. Of particular interest is the development of a gene therapy to
treat airway disease caused by the genetic disorder cystic fibrosis. Gene-addition therapy employs a
vector (non-viral or viral) to deliver wild-type gene copies to the relevant airway cells, with the
ultimate goal of correcting the disease pathophysiology that results from the defective gene. While
gene vectors can be readily delivered into the lung airways, physical, anatomical, and immune
barriers have evolved to protect the host airway cells against airborne pathogens. These natural
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defences are also directed towards gene transfer vectors, thus
limiting gene transduction in the airway epithelium.
Major hurdles to efficient viral-vector mediated gene transfer
include a polarised epithelium, paucity of viral receptors on the
apical membrane, and the presence of airway tight-junctions that
prevent vectors from accessing receptors located on the
basolateral side (Copreni et al., 2004). One way to overcome
these barriers is to perform epithelial perturbation prior to, or in
conjunction with gene transfer vector delivery. Perturbation
methods act to disrupt tight-junction integrity, allowing vector
particles access to basolateral receptors, thus enhancing vector-
mediated gene transfer (Johnson et al., 2000; Pickles, 2004; Kim
et al., 2016). Epithelial perturbation can also potentially expose
cells for transduction that are not in direct contact with the airway
lumen, particularly the basal cells, which function as tissue-
specific stem cells (Rock et al., 2009).
To achieve basolateral access, airway conditioning with a
chemical “tight-junction opener” can be employed to increase
paracellular permeability. Airway conditioning with compounds
including ethylene glycol tetraacetic acid (EGTA) (Chu et al.,
2001), perfluorochemicals (Li et al., 2007), sodium caprate
(Gregory et al., 2003), and sulphur dioxide inhalation
(Johnson et al., 2000) have proven effective for disrupting
tight-junctions and increasing viral-vector mediated gene
transfer in proof-of-principle animal studies (Castellani and
Conese, 2010). Another compound that has been investigated
extensively for this purpose is lysophosphatidylcholine (LPC)
(Limberis et al., 2002; Koehler et al., 2005; Cmielewski et al., 2010;
Cao et al., 2013; Cmielewski et al., 2014). LPC is a natural
component of lung surfactant that can be used to transiently
open cellular tight-junctions when applied to the airway surface.
A two-step dosing regimen employing LPC conditioning prior to
the delivery of a HIV-1-derived lentiviral (LV) vector
pseudotyped with the vesicular stomatitis virus glycoprotein
(VSV-G) has proven effective at increasing airway gene
transfer in mouse nasal airways (Cmielewski et al., 2010;
Cmielewski et al., 2014), but has not yet been assessed in rat
lower airways.
Chemical conditioning approaches have disadvantages when
it comes to performing LV-mediated gene transfer. LV vectors are
highly fragile due to the presence of an outer lipid envelope
(Bandeira et al., 2012) and can be inactivated upon contact with
conditioning agents such as LPC. Although two separate
administrations–one to deliver the conditioning compound,
and then a second to deliver the vector after the chemical
effect occurs–can be used to enable LV vectors to take
advantage of this delivery enhancement effect, this two-step
process increases procedure time and complexity. Additionally,
transduction may be variable as there is no guarantee that the
conditioning compound and the vector will localise to the same
regions (Flotte et al., 2007).
An alternative strategy to disrupt the integrity of the airway
epithelium is via physical perturbation techniques. An early
airway gene therapy study employing an adenoviral vector
demonstrated that externally applied mechanical injury to the
airway epithelium via use of fine forceps is a simple and
effective way to produce strong reporter gene expression in
the trachea of mice. Mechanical perturbation also resulted
in high levels of basal cell transduction as this technique
removed the superficial transduction-resistant columnar
cells thus exposing underlying basal cells to the vector
(Pickles et al., 1996). While early studies validated the
potential efficacy of a physical perturbation strategy, it has
not been investigated further for pre-clinical development,
likely due to the perceived impracticalities of performing
controlled airway-surface perturbation in animal models.
To our knowledge there are no reports of physical airway
injury being used in combination with LV vectors for in vivo
gene delivery.
In this study, physical airway epithelium perturbation was
explored as a strategy to improve in vivo gene transfer levels in the
trachea of rats and this method was compared to standard LPC-
conditioning and a perturbation-free LV-only control group.
Additionally, we provide the first evidence of the effectiveness
of LPC conditioning and LV vector delivery in rat lungs over both
short-term (1-week) and long-term (12-month) durations.
MATERIALS AND METHODS
Multiple treatment groups were employed in this project. The
first study assessed whether LPC had an effect on short- and
long-term gene expression levels. In this study, rats received
LPC conditioning or a PBS-sham treatment, followed by a
HIV-1 derived EF1α-3XFLAG-fLuc-F2A-eGFP vector (LV-
FLAG-Luc-GFP) vector. In one cohort (n  6 per group)
luciferase expression was measured 1-week following gene
delivery, and in a separate cohort (n  12 per group)
expression was measured 12-months after LV delivery. To
investigate and compare airway epithelial disruption
strategies, separate groups of rats received either no
epithelial disruption (control group), physical perturbation,
or standard 0.1% LPC conditioning, followed by delivery of a
HIV-1-MPSV-nlsLacZ vector (LV-LacZ) (n  6 per group).
Gene expression levels were assessed 1-week post gene transfer
in this cohort of animals, as it was expected that the damaged
airway epithelium would be largely regenerated and that gene
expression would be readily apparent by this stage (Shimizu
et al., 1994; Pickles et al., 1996).
Lentiviral Vector Production
LV vector was produced using previously described
methods (Rout-Pitt et al., 2018; McCarron et al., 2019). The
bicistronic LV-FLAG-Luc-GFP vector expressed firefly luciferase
and enhanced green fluorescent protein (eGFP) genes under
control of the EF1α promoter, together with three epitope
FLAG tags. The LV-LacZ vector construct expressed a
nuclear-localised β-galactosidase gene directed by the MPSV
(myeloproliferative sarcoma virus) promoter. LV-FLAG-Luc-
GFP was titered by quantifying the proportion of GFP
positive cells using flow cytometry (McCarron et al., 2019).
The titre of the LV-LacZ vector was determined using real-
time quantitative PCR as previously described (Anson et al.,
2007).
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Animals
All animal procedures were approved by the University of
Adelaide Animal Ethics Committee under applications M-
2016–086 and M-2019–061. Female and male Sprague Dawley
rats aged >8 weeks were used. For all LV-dosing procedures, rats
were anaesthetised with medetomidine (0.4 mg/kg) and ketamine
(60 mg/kg) by intraperitoneal injection. Following anaesthesia,
the rats were non-surgically intubated with a 16-gauge
intravenous cannula (Terumo, SR-FF1651, Japan) acting as an
endotracheal (ET) tube, positioned with the tip just past the
vocal cords so that the majority of the tracheal tissue was exposed
to the conditioning or perturbation and LVvector. Rats that
received physical airway perturbation were given subcutaneous
administration of meloxicam (1 mg/kg) for precautionary pain
relief. After procedure completion anaesthesia was reversed with
atipamezole (1 mg/kg).
Intratracheal Administration of LPC and
Lentiviral Vector
Animals were placed in a supine position and received either
25 µL of 0.1% LPC (Sigma-Aldrich, L4129, USA) or PBS. Fluid
was administered to the trachea via the ET tube using a gel-
loading pipette tip that was lengthened with fine polyethylene
tubing marked to reach the distal tip of the ET tube. LV vector
delivery was performed either without any pre-treatment or one
hour following LPC conditioning (or PBS-sham) as this is the
time when LPC epithelial tight-junction opening effects are
apparent (Cmielewski et al., 2010). LV-FLAG-Luc-GFP (1 ×
109 TU/mL) or LV-LacZ (2 × 109 TU/mL) were delivered to
the trachea in two aliquots of 25 µL (50 µL total per animal).
Physical Epithelial Perturbation
With the intubated animal in the supine position, a pliable wire-
basket (NCircle® Nitinol Tipless Stone Extractor NTSE-022115-
UDH, Cook Medical, USA; Figure 1) was fed in the retracted
position down the ET tube to approximately the carina (based on
an average trachea length measurement). The basket was then
extended, fully expanded, and drawn up and down the trachea
(approximately 10 times per animal) for 30 seconds followed by
withdrawal. Two 25 µL aliquots of LV-LacZ (2 × 109 TU/mL)
were delivered via the ET tube within ten minutes of the
perturbation event.
Bioluminescence Imaging (BLI)
Either 1-week or 12-months following LV-FLAG-Luc-GFP
delivery rats were anaesthetised with 2.5% inhaled isoflurane.
Once unconscious, 200 µL of 15 mg/mL D-luciferin (Cayman
Chemicals, United States) was delivered to the nostrils as a bolus.
Each animal was imaged in the supine position (IVIS Lumina
XRMS in vivo imaging system, PerkinElmer, United States) while
maintained with 1.5–2% isoflurane. Animals were imaged with an
automatic exposure at 5-minute intervals for up to 15 minutes
post D-luciferin delivery. The animals were then humanely killed
with intraperitoneal delivery of sodium pentobarbital
(150–300 mg/kg). The trachea and lungs were immediately
excised and imaged separately in a petri dish containing PBS.
Bioluminescence flux (photons/second) was measured using the
contour tool (Living Image, version 4.7.2, PerkinElmer,
United States).
Assessment of LacZ Gene Expression
Animals were humanely killed by carbon dioxide asphyxiation
and the airway tissues harvested for LacZ staining. Tissues were
fixed in 4% PFA and stained for β-galactosidase (LacZ) activity
using X-gal as previously described (Cmielewski et al., 2017).
Following X-gal staining, the trachea was cut and opened
longitudinally, and separated into two halves. En face images
of the tissue were acquired with a Nikon SMZ1500 stereo
microscope; DigiLite 3.0 MP Camera and TC capture software
(Tucsen Photonics, China). Illumination intensity was not altered
between samples. Tracheas were subsequently paraffin-
embedded, sectioned at 5 μM, and counterstained with nuclear
fast red. Histology images were captured with a Nikon Eclipse
E400 microscope, DS-Fi2-U3 camera and NIS-elements D
software (version 5.20.00).
Immunohistochemistry
X-gal stained sections were deparaffinised and subjected to
heat-mediated antigen retrieval in sodium citrate buffer
(10 mM sodium citrate, 0.05% Tween 20, pH 6.0) at
95–100°C for 20 minutes. A peroxidase blocking step was
performed using 3% hydrogen peroxide followed by
permeabilisation with 0.3% Triton X-100 for 10 minutes.
Protein blocking was performed with 10% goat serum in
PBS. Primary and secondary antibodies were diluted in 1%
bovine serum albumin and 0.1% Triton X-100 in PBS. Sections
were probed with rabbit anti-cytokeratin 5 antibody (Abcam,
ab52635, UK) (1:400 dilution) and were incubated overnight at
4°C. Tissues were washed and subsequently incubated with
goat anti-rabbit IgG HRP (Abcam, ab97051, UK) (1:500
dilution) for 1 hour at room temperature followed by
staining with 3,3′-Diaminobenzidine.
FIGURE 1 | Flexible wire basket used to physically perturb the tracheal
airway epithelium. The basket is 1 cm in diameter at full expansion and 1.5 cm
in length. Scale bar  5 mm.
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Digital Quantification of LacZ Staining in en
Face Trachea Images
The amount of LacZ staining in the en face images of the trachea
was quantified using a custom-written script in Matlab (R2020a,
MathWorks) that calculated the area of the trachea that was the
specific shade of blue/green of LacZ-positive cells. Briefly, images
were converted from the RGB to HSV colour space, and separate
thresholds were applied to the hue (0.45 <H < 0.6) and saturation
(s > 0.4) channels. The value channel was not used because the
illumination across the sample was uneven and did not help
discriminate the transduced cells. A binary mask was created
from the regions of the image that satisfied both criteria. The
mask area was converted from pixels into mm.
Statistical Analyses
Statistical analyses were performed using either R v4.0.0 (Team,
2020) or GraphPad Prism v8 (GraphPad Software, Inc.).
Statistical significance was set at p ≤ 0.05. For the short-term
study, comparisons of flux between PBS and LPC groups were
performed using Welch two sample t-tests on log-transformed
data. To compare flux between the PBS and LPC treatments for
the long-term study, a hurdle regression model was fitted using
the hurdle function in the pscl package in R (Zeileis et al., 2008).
The hurdle regression model is a two-part model; a binary logit
model to distinguish between the positive counts and those below
the detection limit (assigned the value 100), and a zero-truncated
negative binomial model for the positive counts. Treatment (PBS,
LPC) was fitted as the regressor in both parts of the model.
Differences between the groups were assessed using a Wald Chi-
Squared test. The LacZ staining area measurements from the en




Chemical and physical airway perturbation techniques were well-
tolerated by the rats with all animals surviving the procedures.
Animal weight, health and wellbeing characteristics were assessed
daily for the duration of the study using a score-based animal
monitoring system, with no significant effects on animal health
noted. Expected transient weight loss was similar in all
experimental groups (LPC, physical and LV-only), irrespective
of whether airway perturbation was performed (data not shown).
Luciferase Gene Expression Assessed
1-week Post Gene Transfer
In the short-term assessment, rats received either PBS or LPC
conditioning and were imaged 1-week following a single LV gene
delivery. Bioluminescence was predominantly observed in the
lungs in vivo, with only one animal exhibiting signal in the
trachea region (Figure 2). Statistical analysis of the in vivo
data revealed that LPC conditioning resulted in significantly
higher flux when compared to animals that received the PBS
sham treatment (Figure 4A). Upon excision of the tissues and
subsequent imaging, bioluminescence was observed in the
trachea (Figure 3A) and lungs (Figure 3B) of all animals.
Analysis of the ex vivo data indicated that there was no
difference in flux between the LPC and PBS conditioned
groups for the trachea, while the excised lungs revealed that
LPC airway conditioned rats had significantly greater flux levels
(Figure 4A), regardless of the sex of the animals.
Luciferase Gene Expression Assessed
12-months Post Gene Transfer
In the long-term study assessing chemical conditioning, few
animals from either the LPC or PBS group had detectable
levels of in vivo bioluminescence at the 12-month time point
(data not shown), therefore statistical comparisons could not be
performed on this data. Ex vivo imaging of the trachea also
revealed insufficient animals with bioluminescence present to
perform statistical analysis. Imaging of the ex vivo lungs showed
that close to half the animals from both LPC and PBS groups had
values recorded at the limit of bioluminescence detection.
Additionally, the flux levels measured in the ex vivo lungs at
12 months were substantially lower compared to the animals
imaged at 1-week post-delivery. Ex vivo lung imaging revealed
that there was no significant difference in flux between LPC
conditioned and PBS-sham animals’ 12-months following LV-
delivery (Figure 4B).
Tracheal LacZ Gene Expression Following
Chemical Conditioning and Physical
Perturbation
En face observations of the trachea revealed different levels of
LacZ staining as a result of the perturbation or conditioning
method used. Visually, rats that received physical perturbation
prior to LV-delivery demonstrated greatly enhanced LacZ
staining in the trachea when compared to rats that received
LPC conditioning or LV vector-only (Figure 5). Interestingly,
one animal in the physical perturbation group exhibited much
lower staining levels compared to the others, indicative of
potential variability with this technique. The transduction
patterns observed as a result of physical perturbation were not
uniform in appearance. Striated regions of increased staining over
the intercartilaginous ligaments were apparent in all specimens,
possibly reflecting the presence of cilia-rich zones that overlay the
ligament segments in rats (Oliveira et al., 2003) and preferential
transduction of ciliated cells by the VSV-G pseudotyped LV gene
transfer vector. Varying LacZ staining patterns and strong
expression were observed in animals that received physical
perturbation (Figures 6A–F). Notably, rats in the LPC and
LV-only groups demonstrated the highest levels of staining in
the proximal trachea (Supplementary Figure S1), likely due to
unintentional ET tube-induced epithelial damage in this region,
providing further support for the effectiveness of physical
perturbation in boosting airway gene transfer.
Digital quantification of the blue-green coloured regions in the
en face trachea images demonstrated significantly greater levels of
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LacZ staining in the physical perturbation group, when compared
to LPC conditioned and LV vector-only control rats (Figure 7).
The physical damage group demonstrated more than a 1000-fold
increase in the area of LacZ staining when compared to the
control group. There was no statistically significant difference in
staining area between LPC conditioned rats and controls that
received only LV vector with no epithelial disruption prior to
delivery.
Histological Observations Arising From
Physical Perturbation
A range of different cell types were transduced as a result of
performing physical perturbation prior to LV vector delivery.
LacZ-positive ciliated and non-ciliated cells were observed in the
tracheal epithelium (Figures 8A,B) and immunohistochemical
staining for cytokeratin 5 confirmed the presence of transduced
basal cells (Figure 9). Cells within the lamina propria were also
transduced, including suspected macrophages (Figure 8C) and
regions of connective tissue (Figure 8D). Histologically, the
tracheal tissue demonstrated evidence of repair processes
caused by damage to the epithelium and surrounding areas.
Most regions of the tracheal epithelium had fully regenerated
by 1-week post treatment, consistent with the timing observed in
previous studies (Shimizu et al., 1994; Pickles et al., 1996).
However, occasionally areas of epithelium were found to still
be undergoing repair, as indicated by an attenuated appearance,
lack of cilia and rounding of the columnar cells (Figure 8E), or in
other regions, proliferation of connective tissue (Figure 8F).
Goblet cell hyperplasia was also apparent at the carina and
FIGURE 2 | In vivo bioluminescence images acquired 1-week following LV-FLAG-Luc-GFP delivery in PBS-sham and LPC conditioned rats. Localisation of
bioluminescence in vivo was predominantly in the lung region in both PBS and LPC pre-treated animals.
FIGURE 3 | Ex vivo bioluminescence images acquired 1-week following LV-FLAG-Luc-GFP delivery in PBS-sham and LPC conditioned rats. Ex vivo images of (A)
the trachea and (B) lungs following removal of the trachea.
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upper bronchi of two animals (Figure 8G). Interestingly, many of
these hyperplastic goblet cells appeared to be LacZ-positive
(Figure 8H).
DISCUSSION
Gene-addition therapy is a promising option for treatment of
certain pulmonary diseases, but there are still many challenges
to successful translation to the clinic. Adequate delivery of
therapeutic agents to cells of the airway epithelium remains
one of the greatest challenges to achieving effective lung-based
genetic therapies, including gene-addition and gene editing
strategies. The lung has evolved mechanisms to resist invasion
by foreign bodies, with the airway epithelium acting as a
physical barrier that significantly reduces the efficacy of
airway gene transfer. Many viral vectors used for airway
gene therapies have a natural tropism toward receptors
located on the basolateral membrane and thus produce
limited transduction via the apical surface when applied to
an intact airway epithelium.
To overcome inefficient transduction, strategies have been
employed to disrupt the integrity of the airway epithelium prior
to gene delivery, allowing the vector access to basolateral
membrane-located receptors, and to cells that are not in direct
contact with the airway lumen such as basal cells (Pickles, 2004).
Given our recent generation of two cystic fibrosis rat models
(McCarron et al., 2020), the work reported here employed normal
rats to develop and assess chemical and physical airway
perturbation methods. In these studies, the trachea was used a
surrogate for the lower conducting airways, as it is easily accessible
for physical perturbation techniques and the cellular architecture
is similar to human lower airways (Mercer et al., 1994).
In this work, the effectiveness of LPC conditioning was
assessed for the first time in rat airways. While mouse studies
have shown enhanced gene expression when using LPC
conditioning prior to LV gene transfer (Cmielewski et al.,
2014; Cmielewski et al., 2017), its effects in rat airways were
FIGURE 4 | Bioluminescence flux (log scale) acquired 1-week and 12 months following LV-FLAG-Luc-GFP delivery in PBS-sham and LPC conditioned rats. (A) In
vivo and ex vivo bioluminescence flux acquired 1-week post gene transfer. Statistical analyses of the in vivo and ex vivo lung data revealed significant differences in flux
between PBS and LPC conditioned groups, with p  0.0002 and p  0.005, respectively. Statistical analysis of the ex vivo trachea indicated there was no significant
difference in flux between LPC and PBS groups, p  0.2. The plot shows the estimated median and 95% confidence intervals. n  5-6 animals per group,Welch two
sample t-test, ns  not significant, **p ≤ 0.01, ***p ≤ 0.001. (B) Ex vivo lung bioluminescence flux acquired 12 months following gene transfer. The dashed line indicates
the limit of detection of the IVIS machine (102). No significant difference in flux was observed between animals in the PBS and LPC groups, p  0.6. n  11–12 animals per
group, Wald Chi-squared test, ns  not significant.
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unknown. In this study, gene expression levels were found to be
significantly increased in the lungs of rats that received LPC
conditioning when assessed 1-week post vector delivery. Upon in
vivo imaging, only one animal exhibited bioluminescence signal
within the trachea, but following excision of the tissues and
subsequent ex vivo imaging, bioluminescence was observed in
the trachea of all animals, albeit at varying levels. When imaged ex
vivo the flux emitted from the trachea was substantially lower
than the ex vivo lung, therefore the low bioluminescence in
combination with the need to detect the signal through the
overlying skin and tissue may explain the lack of tracheal
bioluminescence upon in vivo imaging. Notably, when the
trachea was excised and imaged, LPC did not appear to
enhance bioluminescence flux when compared to the PBS-
sham group.
Long-term gene expression was assessed in a separate cohort
of rats, which revealed that luciferase gene expression persisted in
the lungs of some animals for up to 12 months following a single
LV-delivery, irrespective of whether LPC airway conditioning
was performed. These two studies indicate that while LPC
conditioning initially improves transduction levels in the
lungs, it does not increase the longevity of gene expression,
suggesting that basal cell transduction was not substantially
enhanced with use of LPC. Nevertheless, it is likely that basal
cells, or other known lung stem cell types (e.g., club cells, alveolar
type II cells), were transduced in animals from both LPC and
PBS-sham groups, as the duration of gene expression exceeds the
four month lifespan of terminally differentiated tracheal-
bronchial epithelium described in adult rodents (Rawlins and
Hogan, 2006).
While LV-mediated gene transfer demonstrated persistent
luciferase gene expression in a proportion of rats, many
individuals from both the LPC conditioning and PBS-sham
groups had undetectable flux by 12 months. The lack of gene
expression observed at the 12 month time point could potentially
be attributed to transgene silencing (Ellis, 2005), alternatively,
loss of gene-expressing cells with natural cell-turnover may
explain this observation. We do not have data that can explain
why some individuals responded better than others, though this
phenomenon is consistently observed in airway gene therapy
animal studies. Possible factors include but are not limited to, the
proportion of basal cells transduced, varying host immune
responses to the vector and formulation, size of the animal
(which dictates the surface area to vector volume ratio),
vector-fluid dynamics and animal respiration rate/depth,
which can result in variable gene vector distribution within
the airways, and the amount of time that the vector is in
contact with the airway surface. An improved understanding
of the basis of these variable individual responses to airway gene-
addition therapy would provide significant value for progressing
to clinical trials.
In the second study employing LV-LacZ vector, physical
perturbation of the airway epithelium resulted in very high
levels of gene transduction in the trachea when compared to
animals receiving LPC chemical conditioning or LV vector-only.
Moreover, LPC conditioning did not significantly enhance
tracheal LacZ expression above the control (LV-only) group,
consistent with the short-term bioluminescence study where LPC
use did not result in a significant increase in tracheal flux when
compared with the PBS-sham group. However, it is important to
note that the LPC conditioning protocol used here had been
previously established for mice, therefore the concentration or
volume employed may not have been optimal for rats.
As with many viral receptors, the VSV-G receptor (low-
density lipoprotein) is located on the basolateral surface, and
transduction via the apical surface is typically low level
(Finkelshtein et al., 2013). While the mechanisms here are not
fully understood, it is likely that physical perturbation increases
gene transfer via two potential routes: 1) disruption of the
integrity of the epithelial tight-junctions allowing the gene
transfer vector entry to epithelial cells via basolateral
receptors, or 2) removal of transduction-resistant columnar
cells and exposure of more susceptible cell types on the
basement membrane (e.g., basal cells). In this study, physical
damage was confirmed to produce basal cell transduction.
Additionally, both en face and histological examination
revealed distinct clusters of LacZ-positive cells, reminiscent of
basal cell clonal expansion observed in previous studies of
induced regeneration following polidocanol epithelial stripping
(Mitomo et al., 2010; Farrow et al., 2018). These clusters suggest
FIGURE 5 | Comparison of en face LacZ staining using physical
perturbation, chemical conditioning with 0.1% LPC, or LV vector-only
assessed 1-week post gene transfer. Images show the trachea from each
individual animal longitudinally cut into two sections to reveal the LacZ
staining present within the lumen. The images display the middle portion of the
trachea and are oriented to show the proximal trachea on the right. n  6 rats
per group. Scale bar  1.5 mm.
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that one or more basal stem cells have been transduced and
subsequently differentiated into a LacZ expressing
pseudostratified epithelium, consistent with previous studies
showing the timing of epithelial regeneration in rat airways
following mechanical injury (Shimizu et al., 1994). However,
further work including lineage tracing studies would be necessary
to confirm this hypothesis. Alternatively, it is possible that
clusters of LacZ-expressing cells may be due to strong focal
damage or repetitive contact with the basket, making these
areas more susceptible to LV-transduction.
Physical perturbation of the airway surface may provide gene
transfer vectors with improved access to basal cells. An airway gene-
addition therapy that transduces only the terminally differentiated
airway surface cells could result in an inevitable waning of transgene
expression with normal cell turnover, and the need for vector
readministration. While repeated administration is unlikely to be
completely avoided, multiple deliveries of a viral-based gene therapy
is undesirable as immune responses may be elicited thus reducing
the efficacy of subsequent doses (Sinn et al., 2009; Mitomo et al.,
2010). Basal cells are multipotent stem cells of the conducting
airways and have the capacity for self-renewal, clonal expansion,
and the ability to differentiate into epithelial cells types to maintain
homeostasis and repair following injury (Hong et al., 2004; Rock
FIGURE 6 | Physical perturbation reveals varying patterns of LacZ staining. (A, B) LacZ staining is increased in the areas overlying the inter-cartilage segments
(C–F) Basket-induced perturbation creates regions of strong staining. High magnification images were acquired from the samples shown in Figure 5 and indicate
staining patterns present in multiple animals. Scale bars A, B  1.5 mm; C-F  0.75 mm.
FIGURE 7 | Quantification of LacZ staining area (log scale) from en face
trachea images shown in Figure 5. Physical perturbation had a significantly
greater area of tracheal LacZ staining after 1-week when compared to LPC
conditioned (p  0.001) and LV vector-only control animals (p  0.0008).
There was no significant difference in the area of LacZ staining between LPC
conditioned animals and those that received only LV vector (p  0.1). The plot
indicates the median. n  6 animals per group, one-way ANOVA with Tukey’s
post-hoc test, ns  not significant, ***p ≤ 0.001. Note that two animals are not
observable on the plot as the quantified area was zero.
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et al., 2009; Rock et al., 2010; Hogan et al., 2014). Successful
transduction of basal cells has the ability to produce enduring
gene expression, as the gene-corrected progeny will repopulate
the surface epithelium following natural cell turnover. It is
therefore desirable to develop an airway gene-addition therapy
that not only produces efficient gene transfer but can also
transduce basal cells (Cao et al., 2018; Farrow et al., 2018).
Following use of physical perturbation, cells within some
regions of the tracheal lamina propria appeared to be
transduced. While a certain degree of epithelial injury was
expected, these findings suggest that in some areas the
physical perturbation extended too far into the airway surface,
likely due to forces produced by the wire basket or repetitive
contact. Goblet cell hyperplasia was also noted in some animals, a
protective response that can occur as a result of mucosal surface
irritation (Herbert et al., 2018). Notably, the animals that
displayed goblet cell hyperplasia had many LacZ-positive
goblet cells within these regions, suggesting that intact basal
cells were transduced and subsequently differentiated into
goblet cells upon epithelial regeneration. Our previous short-
term assessments have shown that VSV-G pseudotyped LV
vectors rarely transduce goblet cells (Limberis et al., 2002;
Farrow et al., 2018), so their presence further indicates likely
expansion and differentiation of transduced basal cells.
One major benefit of physical perturbation noted in this study is
the ability to achieve high transduction levels from a relatively small
number of LV particles per animal (1 × 108 TU). By using physical
epithelial disruption methods to improve gene transfer efficacy, the
LV titres required to achieve therapeutic levels of gene correction
could be reduced, thus improving the feasibility of an in vivo gene
therapy approach. Moreover, such reductions in vector titre would
provide the benefits of lower LV production time and cost, as well as
lessened immune responses. The advantages of physical
perturbation could also be applied to improving the efficacy of
other lung-based genetic therapies including delivery of gene editing
machinery, nanoparticle-based gene transfer systems, and stem cell-
transplantation strategies. For instance, airway engraftment of
transplanted cells could be facilitated via use of physical
perturbation methods rather than chemical agents, which have
previously been employed pre-clinically to achieve epithelial
disruption (King et al., 2020), but have disadvantages such as
toxicity and poor delivery control.
While the results of this tracheal physical perturbation study
provide promising proof-of-principle data, the target for cystic
fibrosis airway gene-addition therapy will be the lower
conducting airways, as this is where disease pathophysiology
occurs. Accordingly, further pre-clinical work in rats is needed
to assess the feasibility of this approach in the lower airways, with
our previously established rat bronchoscopy methods offering a
potential option for enabling access to these small airways for
perturbation. Our minimally invasive miniature bronchoscope
technique provides access to at least the fourth generation of
branching in an adult rat, therefore perturbation-devices could be
guided via the bronchoscope working channel to the small
airways (McIntyre et al., 2018). In addition to rat studies,
investigations using larger animals such as pigs or sheep will
be necessary to identify the features of a perturbation device that
would be considered safe and effective for human clinical use.
Histological assessment of the airway tissue immediately post-
damage, and the time-course of epithelial regeneration following
physical perturbation, will also provide value for understanding the
mechanisms that result in improved gene transfer with this
approach. Future studies should aim to establish more refined
techniques to improve control and reduce the intensity of the
perturbation, so that off-target cell transduction and disruption to
the subepithelial tissue is minimised. Ultimately, a careful balance
between safety, tolerability, and efficacy aspects will be critical in
pursuing this type of physical perturbation approach for human
FIGURE 8 | Histological observations in the tracheal epithelium of rats
that received physical perturbation prior to LV-LacZ vector delivery assessed
1-week post gene transfer. (A) LacZ staining was discontinuous throughout
the tracheal epithelium with some areas of intense staining observed. (B)
A range of LacZ-positive surface epithelial cell types were noted including
ciliated (black arrow) and non-ciliated (white arrow) cells. Transduced regions
were noted within the lamina propria including (C) suspected macrophages
and (D) connective tissue. While most of the tissue demonstrated full
regeneration, some regions showed (E) a flattened epithelial layer lacking
pseudostratification, while other regions demonstrated (F) connective tissue
proliferation (fibrosis) in response to healing (denoted by asterisk). (G) Goblet
cell hyperplasia was found at the carina of two animals with (H) a proportion of
these goblet cells exhibiting LacZ staining. Goblet cells were identified by a
distinct goblet shape and granules filled with mucus. Images are shown from
selected animals. Nuclear fast red counterstain. Scale bar  10 μM.
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airway gene therapy clinical trials. In the interim however, there
remains considerable research value in developing physical
perturbation approaches for pre-clinical investigation.
In summary, although LPC conditioning initially increased
gene expression levels in rat lungs, it did not appear to improve
reporter gene expression longevity. Even without conditioning, a
proportion of rats had measurable flux present in the lungs
12 months following dosing, indicating that a single LV
delivery can provide persistent gene expression, albeit at low
levels. Physical perturbation to the trachea immediately prior to
LV-mediated gene transfer resulted in a 1000-fold increase in
LacZ staining when compared to animals that did not receive any
airway perturbation, demonstrating that this approach can
provide significant benefit for improving gene transfer efficacy
and warrants further development and investigation.
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